TOPPAN (7911) Q3 2026 earnings summary

Executive summary

• Net sales for the nine months ended December 2025 rose 5.2% year-over-year to ¥1,322.8 billion, driven by new business additions and acquisitions, despite the deconsolidation of Tekscend Photomask.

• Non-GAAP operating profit increased 7.9% year-over-year to ¥65.7 billion, offsetting one-time costs and the impact of Tekscend Photomask's transition to equity method.

• Profit attributable to owners of parent declined 19.6% year-over-year to ¥58.1 billion, mainly due to extraordinary income reduction and Tekscend Photomask's removal from consolidation.

• The business environment was marked by geopolitical risks, inflation, FX volatility, and growth in sustainability and digital/AI-driven semiconductor demand.

Financial highlights

• Gross profit margin remained flat year-over-year at 23.5%, despite segment improvements.

• SG&A expenses increased by ¥23.0 billion, with the SG&A-to-sales ratio rising to 20.1%, mainly due to M&A-related costs and higher amortization.

• Ordinary profit decreased 10.6% year-over-year to ¥52.7 billion.

• EBITDA for the nine months was ¥111.6 billion, down 2.1% year-over-year.

• Equity in earnings of affiliates rose to ¥4.2 billion, reflecting Tekscend Photomask's new status as an equity-method associate.

Outlook and guidance

• Full-year net sales forecast remains at ¥1,790.0 billion, with non-GAAP operating profit guidance at ¥97.2 billion.

• Profit attributable to owners of parent is projected at ¥82.5 billion for FY2025.

• Dividend forecast for FY2026 is ¥56.00 per share, unchanged from the previous year.

• No change in guidance from the half-year announcement.